IL321066A - Proccesses for the preparation of an nlrp3 inhibitor - Google Patents

Proccesses for the preparation of an nlrp3 inhibitor

Info

Publication number
IL321066A
IL321066A IL321066A IL32106625A IL321066A IL 321066 A IL321066 A IL 321066A IL 321066 A IL321066 A IL 321066A IL 32106625 A IL32106625 A IL 32106625A IL 321066 A IL321066 A IL 321066A
Authority
IL
Israel
Prior art keywords
proccesses
preparation
nlrp3 inhibitor
nlrp3
inhibitor
Prior art date
Application number
IL321066A
Other languages
Hebrew (he)
Inventor
Satyender Apuri
Sreenivasulu Bandaru
Mallesh Bharatha
Raghavendra Babu CHILIVERI
Jos?Phine Eliette Fran?Oise Cinqualbre
Paul Fraser
Prathap Ireddy
Dainis Kaldre
R?gis Jean Georges MONDI?RE
Jetta Palguna
Alfred Stutz
Paolo Tosatti
Original Assignee
Hoffmann La Roche
Satyender Apuri
Sreenivasulu Bandaru
Mallesh Bharatha
Raghavendra Babu CHILIVERI
Jos?Phine Eliette Fran?Oise Cinqualbre
Paul Fraser
Prathap Ireddy
Dainis Kaldre
R?gis Jean Georges MONDI?RE
Jetta Palguna
Alfred Stutz
Paolo Tosatti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Satyender Apuri, Sreenivasulu Bandaru, Mallesh Bharatha, Raghavendra Babu CHILIVERI, Jos?Phine Eliette Fran?Oise Cinqualbre, Paul Fraser, Prathap Ireddy, Dainis Kaldre, R?gis Jean Georges MONDI?RE, Jetta Palguna, Alfred Stutz, Paolo Tosatti filed Critical Hoffmann La Roche
Publication of IL321066A publication Critical patent/IL321066A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
IL321066A 2022-12-23 2023-12-21 Proccesses for the preparation of an nlrp3 inhibitor IL321066A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202241074900 2022-12-23
EP23158222 2023-02-23
PCT/EP2023/087167 WO2024133610A1 (en) 2022-12-23 2023-12-21 Proccesses for the preparation of an nlrp3 inhibitor

Publications (1)

Publication Number Publication Date
IL321066A true IL321066A (en) 2025-07-01

Family

ID=89507435

Family Applications (1)

Application Number Title Priority Date Filing Date
IL321066A IL321066A (en) 2022-12-23 2023-12-21 Proccesses for the preparation of an nlrp3 inhibitor

Country Status (10)

Country Link
US (1) US20260209178A1 (en)
EP (1) EP4638422A1 (en)
JP (1) JP2026502847A (en)
KR (1) KR20250127071A (en)
CN (1) CN120584100A (en)
AU (1) AU2023413741A1 (en)
IL (1) IL321066A (en)
MX (1) MX2025006623A (en)
TW (1) TW202432131A (en)
WO (1) WO2024133610A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100360130C (en) * 2002-04-18 2008-01-09 先灵公司 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
KR20100125316A (en) * 2008-03-26 2010-11-30 다이이찌 산쿄 가부시키가이샤 Hydroxyquinoxalinecarboxamide derivative
CN110914256A (en) * 2017-07-07 2020-03-24 英夫拉索姆有限公司 Novel sulfonamide carboxamide compounds
GB201817038D0 (en) 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
US12479816B2 (en) * 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors
KR20240024842A (en) * 2021-06-23 2024-02-26 에프. 호프만-라 로슈 아게 Manufacturing process of NLRP3 inhibitor

Also Published As

Publication number Publication date
KR20250127071A (en) 2025-08-26
CN120584100A (en) 2025-09-02
US20260209178A1 (en) 2026-07-23
WO2024133610A1 (en) 2024-06-27
EP4638422A1 (en) 2025-10-29
MX2025006623A (en) 2025-07-01
AU2023413741A1 (en) 2025-02-20
TW202432131A (en) 2024-08-16
JP2026502847A (en) 2026-01-27

Similar Documents

Publication Publication Date Title
IL287042A (en) Nlrp3 inflammasome inhibitors
IL307188A (en) Nlrp3 inhibitors
IL285493A (en) Crystalline forms of an rsk inhibitor
IL318258A (en) Novel nlrp3 inflammasome inhibitors
PT4363406T (en) Nlrp3 inflammasome inhibitors
IL308071A (en) Process for the preparation of nlrp3 inhibitors
IL306022A (en) Inhibitors of nlrp3 inflammasome
IL318533A (en) Nlrp3 inflammasome inhibitors
IL319011A (en) Triazinone derivatives as nlrp3 inhibitors
IL319009A (en) Triazinone derivatives as nlrp3 inhibitors
AU2024255473A1 (en) Pyrazolopyrimidine derivatives as inhibitors of nlrp3
EP4293018A4 (en) Compound serving as nlrp3 inhibitor
GB202307924D0 (en) Inhibitor compounds
GB202300881D0 (en) Inhibitor compounds
CA3274804A1 (en) Proccesses for the preparation of an nlrp3 inhibitor
AU2023413741A1 (en) Proccesses for the preparation of an nlrp3 inhibitor
PT4337652T (en) Nlrp3 inhibitors
HK40109676A (en) Inhibitors of nlrp3
CA3280638A1 (en) Inhibitors of nlrp3
TWI926416B (en) Inhibitor compounds for selective passivation of surfaces
HK40122649A (en) Nlrp3 inhibitors
HK40064714A (en) Crystalline forms of an rsk inhibitor
HK40099180A (en) Inhibitors of nlrp3 inflammasome
CA3288941A1 (en) Pyrazolopyrimidine derivatives as inhibitors of nlrp3
HK40098588A (en) Polymorphs of an ssao inhibitor